Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

David M. Ross, Ilaria S. Pagani, Yazad D. Irani, Jade Clarson, Tamara Leclercq, Phuong Dang, Jennifer McLean, Verity A. Saunders, Lisa Carne, John Reynolds, David S. Ritchie, Deborah L. White, Susan Branford, Timothy P. Hughes, Agnes S.M. Yong

Research output: Contribution to journalLetterOtherpeer-review

Original languageEnglish
Pages (from-to)e56-e60
Number of pages5
JournalBritish Journal of Haematology
Volume186
Issue number3
DOIs
Publication statusPublished - Aug 2019

Keywords

  • chronic myeloid leukaemia
  • immunology
  • treatment-free remission
  • minimal residual disease

Cite this

Ross, David M. ; Pagani, Ilaria S. ; Irani, Yazad D. ; Clarson, Jade ; Leclercq, Tamara ; Dang, Phuong ; McLean, Jennifer ; Saunders, Verity A. ; Carne, Lisa ; Reynolds, John ; Ritchie, David S. ; White, Deborah L. ; Branford, Susan ; Hughes, Timothy P. ; Yong, Agnes S.M. / Lenalidomide maintenance treatment after imatinib discontinuation : results of a phase 1 clinical trial in chronic myeloid leukaemia. In: British Journal of Haematology. 2019 ; Vol. 186, No. 3. pp. e56-e60.
@article{19baf74e2c8f404594fc59e42f570ac6,
title = "Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia",
keywords = "chronic myeloid leukaemia, immunology, treatment-free remission, minimal residual disease",
author = "Ross, {David M.} and Pagani, {Ilaria S.} and Irani, {Yazad D.} and Jade Clarson and Tamara Leclercq and Phuong Dang and Jennifer McLean and Saunders, {Verity A.} and Lisa Carne and John Reynolds and Ritchie, {David S.} and White, {Deborah L.} and Susan Branford and Hughes, {Timothy P.} and Yong, {Agnes S.M.}",
year = "2019",
month = "8",
doi = "10.1111/bjh.15894",
language = "English",
volume = "186",
pages = "e56--e60",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons",
number = "3",

}

Ross, DM, Pagani, IS, Irani, YD, Clarson, J, Leclercq, T, Dang, P, McLean, J, Saunders, VA, Carne, L, Reynolds, J, Ritchie, DS, White, DL, Branford, S, Hughes, TP & Yong, ASM 2019, 'Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia' British Journal of Haematology, vol. 186, no. 3, pp. e56-e60. https://doi.org/10.1111/bjh.15894

Lenalidomide maintenance treatment after imatinib discontinuation : results of a phase 1 clinical trial in chronic myeloid leukaemia. / Ross, David M.; Pagani, Ilaria S.; Irani, Yazad D.; Clarson, Jade; Leclercq, Tamara; Dang, Phuong; McLean, Jennifer; Saunders, Verity A.; Carne, Lisa; Reynolds, John; Ritchie, David S.; White, Deborah L.; Branford, Susan; Hughes, Timothy P.; Yong, Agnes S.M.

In: British Journal of Haematology, Vol. 186, No. 3, 08.2019, p. e56-e60.

Research output: Contribution to journalLetterOtherpeer-review

TY - JOUR

T1 - Lenalidomide maintenance treatment after imatinib discontinuation

T2 - results of a phase 1 clinical trial in chronic myeloid leukaemia

AU - Ross, David M.

AU - Pagani, Ilaria S.

AU - Irani, Yazad D.

AU - Clarson, Jade

AU - Leclercq, Tamara

AU - Dang, Phuong

AU - McLean, Jennifer

AU - Saunders, Verity A.

AU - Carne, Lisa

AU - Reynolds, John

AU - Ritchie, David S.

AU - White, Deborah L.

AU - Branford, Susan

AU - Hughes, Timothy P.

AU - Yong, Agnes S.M.

PY - 2019/8

Y1 - 2019/8

KW - chronic myeloid leukaemia

KW - immunology

KW - treatment-free remission

KW - minimal residual disease

UR - http://www.scopus.com/inward/record.url?scp=85063487180&partnerID=8YFLogxK

U2 - 10.1111/bjh.15894

DO - 10.1111/bjh.15894

M3 - Letter

VL - 186

SP - e56-e60

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -